"The [sell-side indicator] has been a reliable contrarian indicator. In other words, it has been bullish when Wall Street was ...

Societe Generale has predicted 2025 will be the best stock picking period in 25 years, citing reflationary policies from ...

(Reuters) - Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema treatment, Dupixent, and announced a dividend and stock buyback ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) generated around $2.6 billion in free cash flow during the first nine months of 2024 and ended the quarter with $15.6 billion of cash and marketable ...

Regeneron and Illumina have joined a major investment in health data specialist Truveta that will support the creation of a major new genome project. The two companies, along with 17 US health ...

Regeneron's CD20xCD3 bispecific antibody for ... All of the drugs are being positioned as off-the-shelf alternatives to CAR-T cell therapies for NHL, such as Gilead Sciences' Yescarta ...

Shailesh Chandra, MD of passenger vehicles at Tata Motors, said the budget's focus on rural prosperity, coupled with reforms in personal income tax, are likely to help create demand. The two ...

While her extensive car collection includes a lot of the usual suspects, there are also some absolute bangers in there, like a restomod '67 Ford Bronco, a murdered-out third-generation El Camino ...